Home > NewsRelease > The state of medical cannabis
Text
The state of medical cannabis
From:
Michael D. Shaw -- Expert in Health Care and Environmental Affairs Michael D. Shaw -- Expert in Health Care and Environmental Affairs
For Immediate Release:
Dateline: Washington, DC
Saturday, June 29, 2019

 

Medical_cannabisThis HND piece examines the odd disparities and paradoxes in our country's approach to regulating cannabis. Not only are there state-to-state differences, but there is a bizarre situation at the federal level. Even though a particular preparation of cannabidiol is now FDA approved, cannabis is still considered a Schedule I controlled substance. That is, of course, unless the cannabis is that exact preparation of CBD—Epidiolex—which is merely Schedule V.

We contrast this mess with the situation in Australia, where medical cannabis is legal at the federal level throughout the country. It's all about Prohibition, isn't it? To prove this, we reference the work of Fredric Wertham.

Read the complete article.

Interscan Corporation
4590 Ish Drive
Simi Valley, CA 93063-7682

Phone:    1 800 458-6153 (US and Canada)
               (818) 882-2331
FAX:       (818) 341-0642
Web:      www.gasdetection.com
Interscan Twitter

News Media Interview Contact
Name: Michael D. Shaw
Title: Executive VP/Director of Marketing
Group: Interscan Corporation
Dateline: Reston, VA United States
Direct Phone: 703-796-6063
Main Phone: 1 800 458-6153
Cell Phone: 818-481-0626
Jump To Michael D. Shaw -- Expert in Health Care and Environmental Affairs Jump To Michael D. Shaw -- Expert in Health Care and Environmental Affairs
Contact Click to Contact